A return to big blockbuster drug introductions. A renewed focus on innovation. A more favorable climate for merger-and-acquisition activity. Those are some examples of what a Donald Trump White House could mean for the pharmaceutical industry.
As is typical of an industry tied so closely to legislation and the markets, the state of retail pharmacy is typically one in flux. With 2016 in the rearview mirror and both 2017 and a new presidential administration ahead, what are the biggest changes facing the industry?
The United States and Canada may share borders, but the two countries have few similarities when it comes to cosmetics and fragrances. Mass market cosmetics retailers have long envied the access Canadian retailers have to beauty brands that won’t distribute to American counterparts.
Beauty brands are rushing to add apps as a ploy to allow shoppers to experiment with beauty more often, while also eliminating the need for consumers to return products because of disappointment in shades. If a brand doesn’t have an app now, it probably will this year.